Cancer and Oncology Video Sharing Community

Spotlight
Video

Playlist: Systematic Treatment: What Changed in the First Line for 2018?


15:20
John B.A.G. Haanen MD PhD of the The Netherlands Cancer Institute discusses Anti-PD1 PDL1 + anti-VEGFR in Kidney Cancer at the  12th European International Kidney Cancer Symposium 2017
by:kidneycancer | 301 views
17:01
Toni K. Choueiri, MD of the Dana-Farber Cancer Institute discusses the changes in first line kidney cancer treatment for 2018 at the  12th European International Kidney Cancer Symposium 2017
by:kidneycancer | 979 views
14:39
Thomas Powles MD of Barts Cancer Institute discusses the Phase II Study of Atezolizumab With or Without Bevacizumab vs Sunitinib in Untreated Metastatic Renal Cell Carcinoma Patients at the  12th European International Kidney Cancer Symposium 2017
by:kidneycancer | 305 views
06:08
Hans J. Hammers, MD of the University of Texas Southwestern Medical Center discusses Updated Results From a Phase I Study of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Study from the  12th European International Kidney Cancer Symposium 2017
by:kidneycancer | 335 views
Playlist: Systematic Treatment: What Changed in the First Line for 2018?
Description: Kidney Cancer 2017 European Symposium in Munich. Chairs: Tim Eisen & Sylvie Negrier
From: kidneycancer
Videos: 4
More playlists from kidneycancer

Playlist URL: